These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 29225856)
41. Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis. Elizabeth Davis S; Ham J; Hucks J; Gould A; Foster R; Ann Justo J; Nicolau DP; Bookstaver PB Am J Health Syst Pharm; 2019 Apr; 76(8):501-504. PubMed ID: 31361864 [TBL] [Abstract][Full Text] [Related]
42. Molecular Adsorbent Recirculating System (MARS(®)) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure. Ruggero MA; Argento AC; Heavner MS; Topal JE Transpl Infect Dis; 2013 Apr; 15(2):214-8. PubMed ID: 23279615 [TBL] [Abstract][Full Text] [Related]
43. Piperacillin/tazobactam-induced neurotoxicity in a hemodialysis patient: a case report. Neves PD; Freitas FM; Kojima CA; Carmello BL; Bazan R; Barretti P; Martin LC Hemodial Int; 2015 Jan; 19(1):143-5. PubMed ID: 25098503 [TBL] [Abstract][Full Text] [Related]
44. Reversible bone marrow depression by high-dose piperacillin/tazobactam. Ruiz-Irastorza G; Barreiro G; Aguirre C Br J Haematol; 1996 Dec; 95(4):611-2. PubMed ID: 8982034 [TBL] [Abstract][Full Text] [Related]
45. Immune hemolysis due to piperacillin/tazobactam. Garcia Gala JM; Vazquez Aller S; Rodriguez Vicente P; Morante Pombo C Transfus Apher Sci; 2009 Apr; 40(2):97-8. PubMed ID: 19250872 [No Abstract] [Full Text] [Related]
46. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma. Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959 [TBL] [Abstract][Full Text] [Related]
47. Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation. Monogue ML; Pettit RS; Muhlebach M; Cies JJ; Nicolau DP; Kuti JL Antimicrob Agents Chemother; 2016 Nov; 60(11):6578-6584. PubMed ID: 27550351 [TBL] [Abstract][Full Text] [Related]
48. Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis. Kanji S; Roberts JA; Xie J; Alobaid A; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R Ann Pharmacother; 2018 Oct; 52(10):965-973. PubMed ID: 29730948 [TBL] [Abstract][Full Text] [Related]
56. Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study. Viola A; Ferrazzano L; Martelli G; Cerisoli L; Ricci A; Tolomelli A; Cabri W Eur J Pharm Sci; 2019 Aug; 136():104957. PubMed ID: 31202896 [TBL] [Abstract][Full Text] [Related]
57. In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam. Petro D; Mushi MF; Moremi N; Iddi S; Mirambo M; Seni J; Mshana SE Tanzan J Health Res; 2014 Jan; 16(1):54-7. PubMed ID: 26867273 [TBL] [Abstract][Full Text] [Related]
58. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime. Clemmons AB; Bech CF; Pantin J; Ahmad I Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056 [TBL] [Abstract][Full Text] [Related]
59. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam. Nord CE Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987 [TBL] [Abstract][Full Text] [Related]
60. Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations. Öbrink-Hansen K; Jensen-Fangel S; Brock B; Hardlei TF; Adelfred A; Nejatbakhsh Y; Kragh Thomsen M; Petersen E J Cyst Fibros; 2016 Mar; 15(2):e13-4. PubMed ID: 26490337 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]